Bone Therapeutics annonce les résultats de son Assemble Générale Annuelle
June 10, 2021 01:00 ET
|
Bone Therapeutics SA
Approbation de l’ensemble des résolutions par les actionnaires Gosselies, Belgique, le 10 juin 2021, 7h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de...
Bone Therapeutics announces Annual General Meeting results
June 10, 2021 01:00 ET
|
Bone Therapeutics SA
Shareholders approved all resolutions Gosselies, Belgium, 10 June 2021, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical...
Bone Therapeutics fait le point sur ses activités du premier trimestre 2021
May 26, 2021 01:00 ET
|
Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Des avancées cliniques solides, notamment dans l’étude de Phase III évaluant le JTA-004 grâce aux niveaux élevés d’observance et d’adhésion des patients ...
Bone Therapeutics Provides First Quarter 2021 Business Update
May 26, 2021 01:00 ET
|
Bone Therapeutics SA
REGULATED INFORMATION Strong clinical progress especially in JTA-004 Phase III study thanks to high patient compliance and retention Process development partnership and appointment of cell...
Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK
February 11, 2021 04:10 ET
|
Rentschler Biopharma SE
New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansionCenter of Excellence to address the gap in capacity...
Rentschler Biopharma to build new cell and gene therapy capabilities in the UK
February 11, 2021 04:00 ET
|
Rentschler Biopharma SE; The Cell and Gene Therapy Catapult
Rentschler Biopharma will establish their ATMP development and manufacturing capabilities at the Cell and Gene Therapy Catapult facility in StevenageAgreement confirms UK’s global attractiveness for...
Bone Therapeutics et Rigenerand signent un partenariat pour le développement d’un processus de thérapie cellulaire
January 14, 2021 01:00 ET
|
Bone Therapeutics SA
Gosselies, Belgique et Modène, Italie, le 14 janvier 2021, 7h00 CET – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de...
Bone Therapeutics and Rigenerand sign partnership for cell therapy process development
January 14, 2021 01:00 ET
|
Bone Therapeutics SA
Gosselies, Belgium and Modena, Italy, 14 January 2021, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and...
Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
January 11, 2021 08:00 ET
|
LEUKOCARE AG
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Germany-based formulation development specialist Leukocare opens US presence to support local...
Bone Therapeutics to present at 2020 Virtual Cell & Gene Meeting on the Mesa
October 12, 2020 01:00 ET
|
Bone Therapeutics SA
Gosselies, Belgium, 12 October 2020, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases,...